GUT MICROBE-GENERATED METABOLITE TRIMETHYLAMINE-N-OXIDE AND RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH HEART FAILURE

Gut microbiota-derived metabolite trimethylamine-N-oxide (TMAO) have been implicated as a novel risk factor for cardiovascular events. However, the association between TMAO and major adverse cardiovascular events (MACEs) were inconsistent in patients with heart failure (HF). We quantified